» Articles » PMID: 17456009

Inactivation of Pten in Osteo-chondroprogenitor Cells Leads to Epiphyseal Growth Plate Abnormalities and Skeletal Overgrowth

Overview
Date 2007 Apr 26
PMID 17456009
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: To study the role of the Pten tumor suppressor in skeletogenesis, we generated mice lacking this key phosphatidylinositol 3'-kinase pathway regulator in their osteo-chondroprogenitors. A phenotype of growth plate dysfunction and skeletal overgrowth was observed.

Introduction: Skeletogenesis is a complex process relying on a variety of ligands that activate a range of intracellular signal transduction pathways. Although many of these stimuli are known to activate phosphatidylinositol 3'-kinase (PI3K), the function of this pathway during cartilage development remains nebulous. To study the role of PI3K during skeletogenesis, we used mice deficient in a negative regulator of PI3K signaling, the tumor suppressor, Pten.

Materials And Methods: Pten gene deletion in osteo-chondrodroprogenitors was obtained by interbreeding mice with loxP-flanked Pten exons with mice expressing the Cre recombinase under the control of the type II collagen gene promoter (Pten(flox/flox):Col2a1Cre mice). Phenotypic analyses included microcomputed tomography and immunohistochemistry techniques.

Results: MicroCT revealed that Pten(flox/flox):Col2a1Cre mice exhibited both increased skeletal size, particularly of vertebrae, and massive trabeculation accompanied by increased cortical thickness. Primary spongiosa development and perichondrial bone collar formation were prominent in Pten(flox/flox):Col2a1Cre mice, and long bone growth plates were disorganized and showed both matrix overproduction and evidence of accelerated hypertrophic differentiation (indicated by an altered pattern of type X collagen and alkaline phosphatase expression). Consistent with increased PI3K signaling, Pten-deficient chondrocytes showed increased phospho-PKB/Akt and phospho-S6 immunostaining, reflective of increased mTOR and PDK1 activity. Interestingly, no significant change in growth plate proliferation was seen in Pten-deficient mice, and growth plate fusion was found at 6 months.

Conclusions: By virtue of its ability to modulate a key signal transduction pathway responsible for integrating multiple stimuli, Pten represents an important regulator of both skeletal size and bone architecture.

Citing Articles

Extracellular matrix: Dystroglycan interactions-Roles for the dystrophin-associated glycoprotein complex in skeletal tissue dynamics.

Hopkinson M, Pitsillides A Int J Exp Pathol. 2025; 106(2):e12525.

PMID: 39923120 PMC: 11807010. DOI: 10.1111/iep.12525.


Pten knockout in mouse preosteoblasts leads to changes in bone turnover and strength.

Lorenz J, Richter S, Kirstein A, Kolbig F, Nebe M, Schulze M JBMR Plus. 2024; 8(3):ziad016.

PMID: 38505222 PMC: 10945711. DOI: 10.1093/jbmrpl/ziad016.


Knockdown of Kmt2d leads to growth impairment by activating the Akt/β-catenin signaling pathway.

Shangguan H, Huang X, Lin J, Chen R G3 (Bethesda). 2024; 14(3).

PMID: 38263533 PMC: 10917512. DOI: 10.1093/g3journal/jkad298.


Protein tyrosine phosphatases in skeletal development and diseases.

Yang H, Wang L, Shigley C, Yang W Bone Res. 2022; 10(1):10.

PMID: 35091552 PMC: 8799702. DOI: 10.1038/s41413-021-00181-x.


Novel insights into the coupling of osteoclasts and resorption to bone formation.

Durdan M, Azaria R, Weivoda M Semin Cell Dev Biol. 2021; 123:4-13.

PMID: 34756783 PMC: 8840962. DOI: 10.1016/j.semcdb.2021.10.008.